Skip to main content
. 2020 May 8;13:20. doi: 10.1186/s13047-020-00384-1

Table 2.

Outcome measurements

STUDY PERIOD
Enrolment/ Baseline Post-allocation Close-out
TIMEPOINTa t0 t1 t2
ENROLMENT:
 Eligibility screen X
 Informed consent X
 Allocation X
INTERVENTIONS:
 Foot exercise and education
 Brief advice
ASSESSMENTS:
 Participant characteristics X
Primary outcome measures
Feasibility
  Number of eligible participants X
  Willingness to enrol X
  Recruitment rate X
  Adherence X
  Logbook completion X
  Adverse effects X
  Dropout rates X
Credibility
  Borkovec and Nau Questionnaire X X
Acceptability
  Number of sessions attended X
  Adherence to foot exercises X
  Additional treatment sought X
  Early withdrawal X
Secondary outcome measures
Patient reported outcomes
  First step pain in previous week X X
  Worst pain in previous week X X
  Average pain in previous week X X
  Foot and Ankle Ability Measure X X
  Foot Health Status Questionnaire X X
  Global Rating of Change Score X
  Pain Self-Efficacy Scale X X
  Active Australia Survey X X
Physical measurements
  Intrinsic foot muscle morphology (MRI & ultrasound) X X
  Plantar fascia thickness (ultrasound) X X
  Intrinsic foot muscle motor performance X X
  Foot Posture Index X X
  Foot mobility X X
 Ankle dorsiflexion range of motion (standing lunge test) X X
  Toe flexor strength (dynamometry) X X
  Plantar flexor strength (standing heel rise test) X X

at0 = Baseline, t1 = week 12, t3 = end of data collection all participants